86 related articles for article (PubMed ID: 17283126)
21. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
[TBL] [Abstract][Full Text] [Related]
22. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
Mallery DL; Vandenberg CJ; Hiom K
EMBO J; 2002 Dec; 21(24):6755-62. PubMed ID: 12485996
[TBL] [Abstract][Full Text] [Related]
23. Substrates of the BRCA1-dependent ubiquitin ligase.
Starita LM; Parvin JD
Cancer Biol Ther; 2006 Feb; 5(2):137-41. PubMed ID: 16479151
[TBL] [Abstract][Full Text] [Related]
24. BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ.
Bunch H; Jeong J; Kang K; Jo DS; Cong ATQ; Kim D; Kim D; Cho DH; Lee YM; Chen BPC; Schellenberg MJ; Calderwood SK
Open Biol; 2021 Oct; 11(10):210221. PubMed ID: 34610268
[TBL] [Abstract][Full Text] [Related]
25. BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.
Starita LM; Machida Y; Sankaran S; Elias JE; Griffin K; Schlegel BP; Gygi SP; Parvin JD
Mol Cell Biol; 2004 Oct; 24(19):8457-66. PubMed ID: 15367667
[TBL] [Abstract][Full Text] [Related]
26. BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.
Hu Z; Mi S; Zhao T; Peng C; Peng Y; Chen L; Zhu W; Yao Y; Song Q; Li X; Li X; Jia C; Pei H
EMBO J; 2020 Jun; 39(12):e104133. PubMed ID: 32347575
[TBL] [Abstract][Full Text] [Related]
27. L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis.
Zhang F; Yan P; Yu H; Le H; Li Z; Chen J; Liang X; Wang S; Wei W; Liu L; Zhang Y; Ji X; Xie A; Chen W; Han Z; Pu WT; Chen S; Chen Y; Sun K; Ge B; Zhang B
Cell Rep; 2020 Jul; 32(4):107974. PubMed ID: 32726637
[TBL] [Abstract][Full Text] [Related]
28. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages.
Christensen DE; Brzovic PS; Klevit RE
Nat Struct Mol Biol; 2007 Oct; 14(10):941-8. PubMed ID: 17873885
[TBL] [Abstract][Full Text] [Related]
29. Quantitative proteomic identification of the BRCA1 ubiquitination substrates.
Song M; Hakala K; Weintraub ST; Shiio Y
J Proteome Res; 2011 Nov; 10(11):5191-8. PubMed ID: 21950761
[TBL] [Abstract][Full Text] [Related]
30. Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.
Irminger-Finger I; Leung WC; Li J; Dubois-Dauphin M; Harb J; Feki A; Jefford CE; Soriano JV; Jaconi M; Montesano R; Krause KH
Mol Cell; 2001 Dec; 8(6):1255-66. PubMed ID: 11779501
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
[TBL] [Abstract][Full Text] [Related]
32. Negative regulation of BRCA1 by transforming acidic coiled-coil protein 3 (TACC3).
Kim JL; Ha GH; Campo L; Breuer EK
Biochem Biophys Res Commun; 2018 Feb; 496(2):633-640. PubMed ID: 29355525
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 control of steroid receptor ubiquitination.
Heine GF; Parvin JD
Sci STKE; 2007 Jun; 2007(391):pe34. PubMed ID: 17579243
[TBL] [Abstract][Full Text] [Related]
34. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
Ayi TC; Tsan JT; Hwang LY; Bowcock AM; Baer R
Oncogene; 1998 Oct; 17(16):2143-8. PubMed ID: 9798686
[TBL] [Abstract][Full Text] [Related]
35. Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues.
Lombardi G; Falaschi E; Di Cristofano C; Naccarato AG; Sensi E; Aretini P; Roncella M; Bevilacqua G; Caligo MA
Genes Chromosomes Cancer; 2007 Sep; 46(9):791-5. PubMed ID: 17497650
[TBL] [Abstract][Full Text] [Related]
36. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination.
Sankaran S; Starita LM; Groen AC; Ko MJ; Parvin JD
Mol Cell Biol; 2005 Oct; 25(19):8656-68. PubMed ID: 16166645
[TBL] [Abstract][Full Text] [Related]
37. Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking.
Henderson BR
Bioessays; 2005 Sep; 27(9):884-93. PubMed ID: 16108063
[TBL] [Abstract][Full Text] [Related]
38. BARD1 regulates BRCA1-mediated transactivation of the p21WAF1/CIP1 and Gadd45 promoters.
Fabbro M; Henderson BR
Cancer Lett; 2008 May; 263(2):189-96. PubMed ID: 18243530
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
[TBL] [Abstract][Full Text] [Related]
40. The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.
Kleiman FE; Manley JL
Cell; 2001 Mar; 104(5):743-53. PubMed ID: 11257228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
